Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Thrombosis and Haemostasis|November 15, 2023
COVID-19 and Long-COVID Thrombosis: From Clinical and Basic Science to TherapeuticsFrancesco Violi, Job Harenberg, Pasquale Pignatelli, et al.
Pathophysiology of Haemostasis and Thrombosis|January 30, 2009
Non-anticoagulant heparins and inhibition of cancerBenito Casu, Israel Vlodavsky, Ralph D Sanderson
Seminars in Thrombosis and Hemostasis|February 24, 2015
Next generation antithrombotic therapy: focus on antisense therapy against coagulation factor XIGiuseppe Lippi, Job Harenberg, Camilla Mattiuzzi, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 9, 2014
Treatment of deep vein thrombosis in patients with pulmonary embolism: subgroup analysis on the efficacy and safety of certoparin vs. unfractionated heparinHanno Riess, Lena K Becker, Nima Melzer, et al.
Current Pharmaceutical Design|July 14, 2007
Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfateIsrael Vlodavsky, Neta Ilan, Annamaria Naggi, et al.
Thrombosis Journal|August 7, 2013
Concept of a point of care test to detect new oral anticoagulants in urine samplesJob Harenberg, Sandra Krämer, Shanshan Du, et al.
Seminars in Thrombosis and Hemostasis|July 17, 2007
Determination of antithrombin-dependent factor Xa inhibitors by prothrombin-induced clotting timeJob Harenberg, Christina Giese, Antje Hagedorn, et al.
Seminars in Thrombosis and Hemostasis|September 24, 2002
Comparative antithrombotic potencies of direct thrombin inhibitors and low-molecular-weight heparins in an ex vivo human experimental thrombosis modelJob Harenberg, Kawei Zokai, Lukas Piazolo, et al.
European Journal of Clinical Pharmacology|February 20, 2008
Anticoagulant effects of idraparinux after termination of therapy for prevention of recurrent venous thromboembolism: observations from the van Gogh trialsJob Harenberg, Ingrid Jörg, Yvonne Vukojevic, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 12, 2011
Determination of an international sensitivity index of thromboplastin reagents using a WHO thromboplastin as calibrator for plasma spiked with rivaroxabanJob Harenberg, Svetlana Marx, Roland Krämer, et al.
Pageof 13